giovedì 29 gennaio 2015

Edoardo Cignoli : Alexion Pharmaceuticals Names COO to CEO

Alexion Pharmaceuticals Inc. said Thursday that its No. 2 executive would take over as chief executive of the rare-disease drug developer.



via WSJ.com: US Business http://ift.tt/1wFELAk

Nessun commento:

Posta un commento